EchoGen perflenapent emulsion, fluorocarbon-based ultrasound contrast agent: Phase III Update

Sonus Pharmaceuticals Inc. (SNUS), Bothell,

Read the full 54 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE